Cristcot is a global life sciences company headquartered in Massachusetts. The company focuses on unique drug delivery systems, combination products and specialty drug formulations.
Core to the company’s mission, is the philosophy of unobtrusive care where by the performance of the products are measured by the impact they have on the lives of patients and caregivers.
Cristcot is experienced in expedited regulatory approvals including 510k and 505(b)(2) pathways, and targets therapies and products that are historically ignored by the industry. The company safeguards strong commercial launch of it products with the regulatory market exclusivities offered with a 505(b)(2) approval, orphan and new molecular entity designation filings providing 3-7 years market exclusivity.
Utilizing a strong patent strategy, the company secures extended market protection with patents for its technological innovations covering the individual parts and the whole as well as the manufacturing processes. In addition, Cristcot places a strong emphasis on Patents and Trademarks along with highly developed branding to build brands with generational longevity.
The therapeutic areas of primary interest are: Gastroenterology, Neurology and Pain Management.